从药师角度分析肾内科病房药物相关问题及处理。

E. Dvořáčková, J. Rychlíčková, P. Pávek, M. Hojný, J. Vlček
{"title":"从药师角度分析肾内科病房药物相关问题及处理。","authors":"E. Dvořáčková, J. Rychlíčková, P. Pávek, M. Hojný, J. Vlček","doi":"10.1691/ph.2019.9568","DOIUrl":null,"url":null,"abstract":"The main goal of the study was to determine the incidence and the character of drug related problems (DRPs) identified in chronic kidney disease patients by the clinical pharmacist at the nephrology department. As secondary objective, the aim was to identify the frequency and character of DRPs of selected high risk drugs in medication reviews. The clinical pharmacist reviewed patients' medication records and made drug therapy-related recommendations to physicians. The clinical pharmacists' interventions were categorized using an adaptation of the Pharmaceutical Care Network Europe. During the study period (January 2016 - June 2018) the clinical pharmacist performed 1192 interventions in 1870 adult patients admitted to the Nephrology Department. The most frequent DRP was untreated indication 324 (27.18%) of all interventions, and incorrect dose 248 (20.81%). Anti-infectives were identified as the drug category with the highest frequency of interventions. Almost 93% of all interventions were accepted by the attending physicians. Still within the second objectives, underdosing was observed as the most frequent problem for renally excreted drugs. It was found that an incorrect dose is a very frequent issue at the nephrology department. Surprisingly, the main problem was underdosing. In the category of renally excreted drugs, underdosing was observed in antithrombotics and antivirals. The above- mentioned results prove the need of a clinical pharmacist, preferably in sense of maximizing of the treatment effect and improving the care of patients.","PeriodicalId":86039,"journal":{"name":"Die Pharmazie. Beihefte","volume":"15 1","pages":"625-629"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Analysis and management of drug related problems on a nephrology ward from a pharmacist's point of view.\",\"authors\":\"E. Dvořáčková, J. Rychlíčková, P. Pávek, M. Hojný, J. Vlček\",\"doi\":\"10.1691/ph.2019.9568\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The main goal of the study was to determine the incidence and the character of drug related problems (DRPs) identified in chronic kidney disease patients by the clinical pharmacist at the nephrology department. As secondary objective, the aim was to identify the frequency and character of DRPs of selected high risk drugs in medication reviews. The clinical pharmacist reviewed patients' medication records and made drug therapy-related recommendations to physicians. The clinical pharmacists' interventions were categorized using an adaptation of the Pharmaceutical Care Network Europe. During the study period (January 2016 - June 2018) the clinical pharmacist performed 1192 interventions in 1870 adult patients admitted to the Nephrology Department. The most frequent DRP was untreated indication 324 (27.18%) of all interventions, and incorrect dose 248 (20.81%). Anti-infectives were identified as the drug category with the highest frequency of interventions. Almost 93% of all interventions were accepted by the attending physicians. Still within the second objectives, underdosing was observed as the most frequent problem for renally excreted drugs. It was found that an incorrect dose is a very frequent issue at the nephrology department. Surprisingly, the main problem was underdosing. In the category of renally excreted drugs, underdosing was observed in antithrombotics and antivirals. The above- mentioned results prove the need of a clinical pharmacist, preferably in sense of maximizing of the treatment effect and improving the care of patients.\",\"PeriodicalId\":86039,\"journal\":{\"name\":\"Die Pharmazie. Beihefte\",\"volume\":\"15 1\",\"pages\":\"625-629\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Die Pharmazie. Beihefte\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1691/ph.2019.9568\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Die Pharmazie. Beihefte","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1691/ph.2019.9568","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

摘要

本研究的主要目的是确定肾脏内科临床药师在慢性肾脏疾病患者中发现的药物相关问题(DRPs)的发生率和特征。次要目的是确定药物评价中选定的高风险药物的drp的频率和特征。临床药师审查患者的用药记录,并向医生提出药物治疗相关的建议。临床药师的干预措施被分类使用适应的药物护理网络欧洲。在研究期间(2016年1月至2018年6月),临床药师对1870名肾内科住院的成年患者进行了1192次干预。在所有干预措施中,最常见的DRP是未经治疗的适应症324例(27.18%),错误剂量248例(20.81%)。抗感染药物被确定为干预频率最高的药物类别。几乎93%的干预措施被主治医生接受。在第二个目标中,剂量不足被观察到是肾脏排泄药物最常见的问题。研究发现,在肾脏病科,剂量不正确是一个非常常见的问题。令人惊讶的是,主要问题是剂量不足。在肾脏排泄药物类别中,抗血栓药物和抗病毒药物的剂量不足。上述结果证明了临床药师的必要性,最好是在治疗效果最大化和改善患者护理的意义上。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Analysis and management of drug related problems on a nephrology ward from a pharmacist's point of view.
The main goal of the study was to determine the incidence and the character of drug related problems (DRPs) identified in chronic kidney disease patients by the clinical pharmacist at the nephrology department. As secondary objective, the aim was to identify the frequency and character of DRPs of selected high risk drugs in medication reviews. The clinical pharmacist reviewed patients' medication records and made drug therapy-related recommendations to physicians. The clinical pharmacists' interventions were categorized using an adaptation of the Pharmaceutical Care Network Europe. During the study period (January 2016 - June 2018) the clinical pharmacist performed 1192 interventions in 1870 adult patients admitted to the Nephrology Department. The most frequent DRP was untreated indication 324 (27.18%) of all interventions, and incorrect dose 248 (20.81%). Anti-infectives were identified as the drug category with the highest frequency of interventions. Almost 93% of all interventions were accepted by the attending physicians. Still within the second objectives, underdosing was observed as the most frequent problem for renally excreted drugs. It was found that an incorrect dose is a very frequent issue at the nephrology department. Surprisingly, the main problem was underdosing. In the category of renally excreted drugs, underdosing was observed in antithrombotics and antivirals. The above- mentioned results prove the need of a clinical pharmacist, preferably in sense of maximizing of the treatment effect and improving the care of patients.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信